We measured the levels of total VWF, unfolded VWF and VWF pro-peptide in a cohort of 93 normal controls, 54 thrombotic APS patients, 39 non-APS thrombosis patients and 49 non-APS AID patients (Table 1). This evidence concerns the gene VWF and autoimmune polyendocrinopathy.